Clinical, neuroimaging, and genetic markers in cerebral amyloid angiopathy-related inflammation: a systematic review and meta-analysis
A Theodorou, L Palaiodimou, K Malhotra, C Zompola… - Stroke, 2023 - Am Heart Assoc
Background: There are limited data regarding the prevalence of distinct clinical,
neuroimaging and genetic markers among patients diagnosed with cerebral amyloid …
neuroimaging and genetic markers among patients diagnosed with cerebral amyloid …
Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review
A Theodorou, L Palaiodimou, A Safouris… - Journal of Clinical …, 2022 - mdpi.com
Background: Limited data exist regarding the prevalence of clinical, neuroimaging, and
genetic markers among patients diagnosed with Cerebral Amyloid Angiopathy–related …
genetic markers among patients diagnosed with Cerebral Amyloid Angiopathy–related …
Neuroimaging to Facilitate Clinical Trials in Huntington's Disease: Current Opinion from the EHDN Imaging Working Group
NZ Hobbs, M Papoutsi, A Delva… - Journal of …, 2024 - content.iospress.com
Neuroimaging is increasingly being included in clinical trials of Huntington's disease (HD)
for a wide range of purposes from participant selection and safety monitoring, through to …
for a wide range of purposes from participant selection and safety monitoring, through to …
[引用][C] 脑淀粉样血管病相关炎症文献综述
邹璇， 赵文娟， 孔孟丹 - 中风与神经疾病杂志, 2021 - zfysjjbzz.com
脑淀粉样血管病(Cerebral amyloid angiopathy, CAA) 是老年人常见的自发性出血原因, 是Aβ
淀粉样蛋白在软脑膜和皮质动脉内沉积导致的复发性脑叶出血, 1907 年首次被报道 …
淀粉样蛋白在软脑膜和皮质动脉内沉积导致的复发性脑叶出血, 1907 年首次被报道 …